Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

ELRIG

  1. Events
  2. Organisers
  3. ELRIG
Events from this organiser
Today

ELRIG’s Scottish Forum

Scotland has a rich legacy of innovation and drug discovery, with breakthroughs like Fleming’s penicillin and Isaacs’ interferon continuing to impact the world today. Home [...]

Drug Discovery 2025

ELRIG’s Drug Discovery conference returns to Liverpool, continuing its reputation as Europe’s leading event for Drug Discovery and Life Sciences. This year’s scientific programme will [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top